Stem cell plasticity: Recapping the decade, mapping the future

Slides:



Advertisements
Similar presentations
Oxidative stress and hypoxia in normal and leukemic stem cells Ugo Testa, Catherine Labbaye, Germana Castelli, Elvira Pelosi Experimental Hematology Volume.
Advertisements

GSK3β inhibition activates the CDX/HOX pathway and promotes hemogenic endothelial progenitor differentiation from human pluripotent stem cells Kenji Kitajima,
Fabian Mohr, Konstanze Döhner, Christian Buske, Vijay P.S. Rawat 
Experimental Hematology
Susanne Wingert, Michael A. Rieger  Experimental Hematology 
Wound Healing: A Paradigm for Regeneration
The migration of hematopoietic progenitors from the fetal liver to the fetal bone marrow: Lessons learned and possible clinical applications  Jesús Ciriza,
Ling Guo, Robert C.H. Zhao, Yaojiong Wu  Experimental Hematology 
Nishitha M. Reddy, Olalekan Oluwole, John P. Greer, Brian G
Cassie J. Clarke, Tessa L. Holyoake  Experimental Hematology 
Granulocyte colony-stimulating factor receptor signaling in severe congenital neutropenia, chronic neutrophilic leukemia, and related malignancies  Pankaj.
Reprogramming toward Heart Regeneration: Stem Cells and Beyond
Perspective: Stem cells react
Cardiac stem cell therapy: Checkered past, promising future?
Andrew G. Muntean, Jay L. Hess  Cancer Cell 
David G. Zacharias, BA, Timothy J. Nelson, MD, PhD, Paul S
Portrait of a Stem Cell Developmental Cell
Biology of stem cells: an overview
The potential of umbilical cord blood multipotent stem cells for nonhematopoietic tissue and cell regeneration  Carmella van de Ven, Daniel Collins, M.
Unveiling the Role of Senescence-Induced Cellular Plasticity
Benjamin D. Humphreys  Kidney International Supplements 
Stem Cells and Drug Discovery: The Beginning of a New Era?
Miki Ando, Hiromitsu Nakauchi  Experimental Hematology 
Ya-Huei Kuo, Jing Qi, Guerry J. Cook  Experimental Hematology 
Development in Motion: Helper T Cells at Work
Hematopoiesis from embryonic stem cells: lessons from and for ontogeny
Plasticity of Adult Stem Cells
Atsushi Miyajima, Minoru Tanaka, Tohru Itoh  Cell Stem Cell 
Kinetics and symmetry of divisions of hematopoietic stem cells
CBP/Catenin antagonists: Targeting LSCs’ Achilles heel
Getting blood from bone: An emerging understanding of the role that osteoblasts play in regulating hematopoietic stem cells within their niche  Yusuke.
Reserve Stem Cells in Intestinal Homeostasis and Injury
Marking of definitive HSC precursors in E7. 5–E8
Quiescence regulators for hematopoietic stem cell
Oceans of opportunity: Exploring vertebrate hematopoiesis in zebrafish
Induced pluripotent stem cell modeling of malignant hematopoiesis
Volume 35, Issue 3, Pages (August 2002)
Xiaoou Zhou, Malcolm K. Brenner  Experimental Hematology 
Mira Jeong, Margaret A. Goodell  Experimental Hematology 
Christopher E. Schmitt, Carlos O. Lizama, Ann C. Zovein 
Stem cell plasticity revisited: The continuum marrow model and phenotypic changes mediated by microvesicles  Peter J. Quesenberry, Mark S. Dooner, Jason.
Eun-ju Lee, Pankaj Godara, David Haylock  Experimental Hematology 
Susanne Wingert, Michael A. Rieger  Experimental Hematology 
A dual role of Erk signaling in embryonic stem cells
From pluripotent stem cells to T cells
660. Bowel/Bladder Sensation and Control in Patients with Spinal Cord Injury Treated with Human Embryonic Stem Cell Therapy  Geeta Shroff  Molecular Therapy 
Impact of HDAC inhibitors on dendritic cell functions
Raquel Espín-Palazón, David Traver  Experimental Hematology 
Optimizing autologous cell grafts to improve stem cell gene therapy
Inside This Issue Experimental Hematology
Sietske T. Bakker, Emmanuelle Passegué  Experimental Hematology 
Nick Barker, Alexander van Oudenaarden, Hans Clevers  Cell Stem Cell 
Fabian Mohr, Konstanze Döhner, Christian Buske, Vijay P.S. Rawat 
Tumor necrosis factor α in the onset and progression of leukemia
Pharmacological activation of wild-type p53 in the therapy of leukemia
AGEs in foods: Do they play a role in uremia?
Kinase signaling and targeted therapy for primary myelofibrosis
Reprogramming the kidney: a novel approach for regeneration
Ashley A. Newcombe, Brenda E.S. Gibson, Karen Keeshan 
740. Prevention of Radiation-Induced Lung Injury by Administration of Gene-Modified Mesenchymal Stem Cells    Molecular Therapy  Volume 20, Pages S285-S286.
Cardiac Stem Cell Therapy and the Promise of Heart Regeneration
Erratum Experimental Hematology
Stem cell biology and the plasticity polemic
Circulating miRNA panel for prediction of acute graft-versus-host disease in lymphoma patients undergoing matched unrelated hematopoietic stem cell transplantation 
Neil D. Theise, Reichiro Kuwahara  Gastroenterology 
Matthew I. Stein, Jiang Zhu, Stephen G. Emerson 
Mesp1 at the Heart of Mesoderm Lineage Specification
Special Stem Cells for Bone
Pediatric leukemia: Moving toward more accurate models
Cellular Alchemy and the Golden Age of Reprogramming
Presentation transcript:

Stem cell plasticity: Recapping the decade, mapping the future Neil D. Theise  Experimental Hematology  Volume 38, Issue 7, Pages 529-539 (July 2010) DOI: 10.1016/j.exphem.2010.04.013 Copyright © 2010 ISEH - Society for Hematology and Stem Cells Terms and Conditions

Figure 1 Pathways of cell plasticity. 1: Canonical cell lineage differentiation pathways of both development and adult tissue maintenance and repair. Shifts between one pathway or another respond to the tissue or systemic needs of the organism, either as preprogrammed processes or as a repair/regeneration reaction to injury. 2: Dedifferentiation and redifferentiation may be seen when adult cells return to a blastema-like state in response to injury, then differentiating into differentiated cell populations as part of repair or regeneration. This is most commonly recognized in amphibians, but is also well-documented in fetal mammals (including humans) and in some adult mammals, as well. Such a process may be demonstrable in human neoplasias. 3: The change from one lineage to another in response to cues from the microenvironment is the pathway most often referred to as “plasticity” in the last decade and engendered the most controversy. The degree to which this takes place in living organisms depends on whether there is injury and, if it is present, its nature and severity. Although the physiologic role of this process may still be debated, evidence in adult mammals that it does take place to some degree is well-documented. How to manipulate it for therapeutic and/or industrial purposes is the pressing question. 4: Nuclear reprogramming by cell-to-cell fusion (a), sometimes followed by nuclear fusion (b) is also well-documented. Moreover, postfusion reduction division (c) has also been confirmed. Like the pathway of direct differentiation, the degree to which cell-to-cell fusion, with or without subsequent reduction division, plays significant physiologic roles is not yet clear. Experimental Hematology 2010 38, 529-539DOI: (10.1016/j.exphem.2010.04.013) Copyright © 2010 ISEH - Society for Hematology and Stem Cells Terms and Conditions